Foley Todd
SEC CIK 1473930 · EDGAR
BoughtSold
Most active insiders at AKTS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NODELMAN OLEG | Dir | $40.00M | — |
| 2 | MPM ONCOLOGY INNOVATIONS FUND LP | 10% | $20.03M | — |
| 3 | GADICKE ANSBERT | 10% | $20.03M | — |
| 4 | VIDA VENTURES II-A, LLC | 10% | $15.03M | — |
| 5 | Kim Helen Susan | Dir, 10% | $15.03M | — |
| 6 | Foley Todd | Dir, 10% | $4.19M | — |
| 7 | Czibere Akos | Chief Medical Off | — | $1.65M |
| 8 | Ron-Bigger Shulamit | COO | — | $1.39M |
| 9 | Herrmann Ken | Dir | — | $196.5K |
| 10 | Segal Lloyd Mitchell | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-01-14 | 2026-01-12 | AKTS | Aktis Oncology, Inc. | Foley Todd | Dir, 10% | C - Cnv Deriv | — | +4.00M | 4.00M | New | — |
| DI | 2026-01-14 | 2026-01-12 | AKTS | Aktis Oncology, Inc. | Foley Todd | Dir, 10% | P - Purchase | $18.00 | +232.9K | 4.24M | +6% | +$4.19M |
| DMI | 2021-11-04 | 2021-11-02 | TRDA | Entrada Therapeutics, Inc. | Foley Todd | Dir, 10% | C - Cnv Deriv | — | +4.33M | 3.82M | New | — |
| DI | 2021-11-04 | 2021-11-02 | TRDA | Entrada Therapeutics, Inc. | Foley Todd | Dir, 10% | P - Purchase | $20.00 | +100.0K | 4.43M | +2% | +$2.00M |
Purchase Sale Sale after option exercise All abbreviations